WallStreetZenWallStreetZen

NASDAQ: MTRI
Mentari Therapeutics Inc Stock Ownership - Who owns Mentari Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mentari Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Adar1 Capital Management LLC10% Owner2026-11-052,640$13.10
$34.57kBuy
Adar1 Capital Management LLC10% Owner2026-10-234$1.32
$5.28Buy
Adar1 Capital Management LLC10% Owner2026-10-191,086$1.32
$1.43kBuy
Adar1 Capital Management LLC10% Owner2026-10-161$1.32
$1.32Buy
Adar1 Capital Management LLC10% Owner2026-10-15984$1.32
$1.30kBuy
Adar1 Capital Management LLC10% Owner2026-10-148,021$1.33
$10.67kBuy
Adar1 Capital Management LLC10% Owner2026-10-13564$1.33
$750.12Buy
Adar1 Capital Management LLC10% Owner2026-10-082,256$1.33
$3.00kBuy
Adar1 Capital Management LLC10% Owner2026-10-073,046$1.33
$4.05kBuy
Adar1 Capital Management LLC10% Owner2026-10-065,601$1.33
$7.44kBuy

1 of 5

MTRI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MTRI insiders and whales buy or sell their stock.

MTRI Shareholders

What type of owners hold Mentari Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Opportunity LLC148.91%818,076$13.09MInsider
Shane Aaron Johnson106.12%583,023$9.33MInsider
Adar1 Capital Management LLC78.22%429,746$6.88MInsider
Eric A. Adams8.00%43,959$703.34kInsider
Andrew Hull6.96%38,258$612.13kInsider
Bruce Colwill2.10%11,515$184.24kInsider
Adar1c0.15%800$12.80kInstitution
Adar1 Capital Management LLC0.15%800$12.80kInstitution
Vivo Capital LLC0.15%798$12.77kInstitution
Vivoca0.15%798$12.77kInstitution

1 of 3

MTRI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MTRI0.14%99.86%Net BuyingNet Buying
ENVB0.01%15.55%
ALZN0.01%99.99%Net BuyingNet Selling
PBM0.00%100.00%
ENSC0.00%20.27%Net Buying
View Top Biotech Stocks

Mentari Therapeutics Stock Ownership FAQ

Who owns Mentari Therapeutics?

Mentari Therapeutics (NASDAQ: MTRI) is owned by 0.49% institutional shareholders, 350.32% Mentari Therapeutics insiders, and 0.00% retail investors. Vivo Opportunity LLC is the largest individual Mentari Therapeutics shareholder, owning 818,076.00 shares representing 148.91% of the company. Vivo Opportunity LLC's Mentari Therapeutics shares are currently valued at $9.98M.

If you're new to stock investing, here's how to buy Mentari Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.